460 related articles for article (PubMed ID: 29259518)
1. Genome Surgery and Gene Therapy in Retinal Disorders.
Chan L; Mahajan VB; Tsang SH
Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
Rasoulinejad SA; Maroufi F
Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
[TBL] [Abstract][Full Text] [Related]
3. Gene editing prospects for treating inherited retinal diseases.
Benati D; Patrizi C; Recchia A
J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 genome surgery for retinal diseases.
Xu CL; Park KS; Tsang SH
Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
6. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
7. Let There Be Light: Gene and Cell Therapy for Blindness.
Dalkara D; Goureau O; Marazova K; Sahel JA
Hum Gene Ther; 2016 Feb; 27(2):134-47. PubMed ID: 26751519
[TBL] [Abstract][Full Text] [Related]
8. The application and progression of CRISPR/Cas9 technology in ophthalmological diseases.
Hu X; Zhang B; Li X; Li M; Wang Y; Dan H; Zhou J; Wei Y; Ge K; Li P; Song Z
Eye (Lond); 2023 Mar; 37(4):607-617. PubMed ID: 35915232
[TBL] [Abstract][Full Text] [Related]
9. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.
Zaneveld J; Wang F; Wang X; Chen R
Sci China Life Sci; 2013 Feb; 56(2):125-33. PubMed ID: 23393028
[TBL] [Abstract][Full Text] [Related]
10. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and genome surgery in the retina.
DiCarlo JE; Mahajan VB; Tsang SH
J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
[TBL] [Abstract][Full Text] [Related]
12. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
[TBL] [Abstract][Full Text] [Related]
13. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
Chuang K; Fields MA; Del Priore LV
Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
[TBL] [Abstract][Full Text] [Related]
14. CRISPR genome engineering for retinal diseases.
Kantor A; McClements ME; Peddle CF; Fry LE; Salman A; Cehajic-Kapetanovic J; Xue K; MacLaren RE
Prog Mol Biol Transl Sci; 2021; 182():29-79. PubMed ID: 34175046
[TBL] [Abstract][Full Text] [Related]
15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
Sanjurjo-Soriano C; Kalatzis V
Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
[TBL] [Abstract][Full Text] [Related]
16. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
[TBL] [Abstract][Full Text] [Related]
17. CRISPR in the Retina: Evaluation of Future Potential.
Cho GY; Justus S; Sengillo JD; Tsang SH
Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158
[TBL] [Abstract][Full Text] [Related]
18. Genome-Editing Strategies for Treating Human Retinal Degenerations.
Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K
Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing in Retinal Diseases using CRISPR Technology.
Yiu G
Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
[No Abstract] [Full Text] [Related]
20. With First CRISPR Trials, Gene Editing Moves Toward the Clinic.
Hampton T
JAMA; 2020 Apr; 323(16):1537-1539. PubMed ID: 32267478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
